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High dietary salt intake was reported to increase blood pressure by numerous studies, but
no  study has investigated the effect of dietary salt intake on blood pressure variability
(BPV). This study aimed to determine if daily salt intake is related to ambulatory BPV. The
study included 136 primary hypertensive patients (92 male, 44 female) with a mean age of
50.7 ± 11.1 years. All the patients underwent 24-h ambulatory blood pressure monitoring to
determine both the 24-h systolic and 24-h diastolic BPV. 24-h urine sodium was measured.
The correlation between BPV and 24-h urinary sodium was investigated. Logarithmic trans-
formation of 24-h urinary sodium [log(24-h urinary sodium)] was positively correlated with
the  mean 24-h systolic ARV, and nighttime systolic ARV (r = 0.371 and p = 0.001, r = 0.329 and
p  = 0.028, respectively). Similarly, log(24-h urinary sodium) was positively correlated with
mean 24-h diastolic ARV and nighttime diastolic ARV (r = 0.381 and p = 0.001, r = 0.320 and
p  = 0.020 respectively). Log(24-h urinary sodium) was an independent predictor of BPV based
on  multivariate regression analysis. Dietary salt intake might play a role in the pathogenesis
of  ambulatory BPV.
© 2016 Sociedad Espan˜ola de Nefrologı´a. Published by Elsevier Espan˜a, S.L.U. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Relación  entre  el  consumo  de  sal  y  la  variabilidad  de  la  presión  arterial
ambulatoria  en  pacientes  hipertensos  no  diabéticos
r  e  s  u  m  e  nPalabras clave:
Consumo de sal
Variabilidad de la presión arterial
Hipertensión
En numerosos estudios se ha sen˜alado que el consumo elevado de sal aumenta la presión
arterial; no obstante, no se ha investigado el efecto de la ingesta alimenticia de sal sobre
la  variabilidad de la presión arterial (VPA). El objetivo de este estudio fue determinar si el
consumo diario de sal está relacionado con la VPA ambulatoria. En el estudio se incluyeron
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136 pacientes hipertensos esenciales (92 hombres y 44 mujeres) con una edad media de
50,7  ± 11,1 an˜os. Todos los pacientes se sometieron a una monitorización ambulatoria de
la  presión arterial de 24 h para determinar la VPA sistólica y diastólica de 24 h. Se midió
la  natriuria de 24 h y se estudió la correlación de la misma con la VPA. La transformación
logarítmica de la natriuria de 24 h (log [natriuria 24 h]) se relacionó con certeza con el índice
Average Real Variability (ARV) sistólico de 24 h y el ARV sistólico nocturno medios (r = 0,371 y
p  = 0,001, r = 0,329 y p = 0,028, respectivamente). De forma parecida, el log [natriuria 24 h] se
relacionó con seguridad con el ARV diastólico de 24 h y el ARV diastólico nocturno medios
(r  = 0,381 y p = 0,001, r = 0,320 y p = 0,020, respectivamente). El log [natriuria 24 h] fue una
variable independiente de la VPA, según el análisis de regresión multivariante. Es posible
que el consumo de sal intervenga en la patogénesis de la VPA ambulatoria.
©  2016 Sociedad Espan˜ola de Nefrologı´a. Publicado por Elsevier Espan˜a, S.L.U. Este es un
artı´culo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/
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Cntroduction
ypertension is a primary risk factor for cardiovascular and
erebrovascular diseases, and renal failure. It is well known
hat the quantity of dietary salt intake plays a role in the
athogenesis of primary hypertension. Increased sensitivity
f blood pressure to excess sodium affects 50% of patients
ith primary hypertension.1,2 Dietary salt intake causes an
ncrease in blood pressure, and is associated with renal
nd cardiovascular diseases, including left ventricular hyper-
rophy and microalbuminuria.3–5 Spontaneous variation in
lood pressure is referred to as blood pressure variability
BPV), and is classiﬁed as short-term BPV and long-term
PV.6,7 Fluctuation during a 24-h period is referred to as
hort-term BPV and is based on 24-h ambulatory blood pres-
ure monitoring (ABPM). Variation between successive ABPM
easurements is known as average real variability (ARV),
hich is mathematically calculated.8,9 BPV was reported to
e associated with hypertension-related target organ dam-
ge and cardiovascular mortality, independent of the blood
ressure level. BPV, therefore, becomes more  important day-
y-day.10–13 The pathophysiology of BPV is not fully known;
owever, it was reported that short-term BPV is primarily
ndicative of the effects of central and reﬂex autonomic modu-
ation, and is associated with humoral, rheological, emotional,
nd behavioral factors.9,14–18 The relationship between dietary
alt intake and ambulatory BPV is not clearly known. Dietary
alt intake is known to adversely affect the cardiovascular sys-
em, independent of the blood pressure level.3,5 Excretion of
odium in 24-h urine is a measurement with proven validity
hat is commonly used to measure daily salt intake.19,20 The
im of the present study was to determine if the quantity of
aily salt intake is associated with ambulatory BPV.
aterials  and  methods
tudy  populationhis study was performed at Ankara Numune Education
nd Research Hospital, Nephrology and Internal Medicine
linic, Ankara, Turkey, and included 136 patients thatby-nc-nd/4.0/).
presented between April 2013 and July 2013, and were
diagnosed as primary hypertension. Exclusion criteria were
diabetes mellitus, secondary hypertension, pregnancy, body
mass index (BMI) > 30 kg/m2, malignancy, rheumatic diseases,
acute/chronic infection, liver disease, thyroid gland disease,
adrenal insufﬁciency, syndrome of inappropriate antidiuretic
hormone secretion, nephritis with salt loss, renal tubular acid-
osis, and a glomerular ﬁltration rate <70 mL/min/1.73 m2 and
diuretic use. Duration of hypertension [years) was calculated
based on patient self-reports of the date they were ﬁrst diag-
nosed as hypertension to the date of inclusion in the study.
The study was conducted in accordance with the Declaration
of Helsinki and the study protocol was approved by the Ankara
Numune Education and Research Hospital Ethics Committee.
All the patients provided written informed consent to partic-
ipate in the study.
Laboratory  procedures
Blood samples were collected at 08.00–10.00, following
overnight fasting. Laboratory evaluations included whole
blood count, fasting blood glucose, urea, creatinine, sodium,
potassium, total protein, and albumin. The GFR was cal-
culated using the Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) equation: GFR = 141 × min  (Scr/,1)˛ ×
max(Scr/,1)−1.209 × 0.993age × 1.018 [if female] × 1.159.21
24-h  urine  collection
Patients were asked to collect 24-h urine; they were instructed
not to save the urine from their ﬁrst urination the morn-
ing they started to collect their urine, and to urinate into a
collection container every time thereafter, including the ﬁrst
urination the following morning, and then to bring all col-
lected urine to the laboratory. Patients were told not to make
any changes to their daily dietary salt intake and to follow their
normal diet during the time of urine collection. Urine sodium
was measured in the patients’ 24-h urine via the enzymatic
colorimetric method using a Hitachi Modular P800 (Roche
Diagnostic Corp. Indiana, USA) autoanalyzer. For each individ-
ual the 24-h sodium excretion value (mmol/d) was calculated
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Table 1 – Demographic, laboratory characteristics and
ABPM results of all patients.
Variables All populations (n = 136)
Age (years) 50.78 (11.1)
Gender (n, %)
Male 92 (67.6)
Female 44 (32.4)
BMI (kg/m2) 29.16 (4.5)
Duration of HT (yeras) 3 (1–20)
Anti-hypertensive drug class (n, %)
RAS blocker 66 (48.5)
Beta blocker 24 (17.6)
Calcium channel blocker 72 (52.9)
GFR (mL/min/1.73 m2) 97.57 (10.2)
Serum sodium 141.11 (2.1)
Glucose (mg/dL) 89.94 (5.7)
Albumin (g/dL) 46.28 (2.8)
Creatinine (mg/dL) 0.79 (0.1)
Triglyceride(mg/dL) 157 (61–735)
LDL (mg/dL) 122.52 (35.5)
24-h urine sodium (mmol/d) 152 (21–387)
24-h urine protein (mg/d) 89.63 (6–1949)
24-h systolic ARV 12.33 (3.4)
24-h diastolic ARV 9.77 (2.6)
Nighttime systolic ARV 11.16 (3.9)
Nighttime diastolic ARV 8.78 (2.9)
24-h SBP (mmHg) 122.48 (13.2)
24-h DBP (mmHg) 76.29 (8.50)
Parameters were expressed as mean ± SD or median. Abbreviations:
ARV, average real variability; BMI, body mass index; DBP, diastolic
blood pressure; GFR, glomerular ﬁltration rate; LDL, low density696  n e f r o l o g i a 2
as the concentration of sodium in the urine (mmol/L) × urinary
volume (L/d).
Ambulatory  blood  pressure  monitoring  and  its  variability
A WatchBP 03 device (Microlife WatchBP AG, Switzerland) was
attached to all patients for 24-h ABPM the morning they began
to collect 24-h urine. The ABPM device was set to take mea-
surements every 20 min  between 08.00 and 23.00 (daytime),
and every 30 min  between 23.00 and 08.00 (nighttime). Patients
were told to perform their normal daily activities, but not
to bend their arm during measurements. These measure-
ments provided 24-h systolic and 24-h diastolic blood pressure
values. The method was considered reliable if >70% of mea-
surements were valid. BPV was mathematically calculated as
the blood pressure values from 24-h ABPM and the ARV index,
using the following formula:ARV = 1N−1
N−1∑
k=1
|BPk+1 − BPk|where
N is the number of valid blood pressure measurements, and
BPk+1 and BPk represent 2 successive blood pressure mea-
surements. The rationale for selecting the ARV index for BPV
calculation was based on an earlier study that reported the
ARV index was a more  reliable index for establishing the pro-
gnostic signiﬁcance of BPV.8
Statistical  analysis
Statistical analysis was performed using SPSS v.20.0 for Win-
dows (SPSS, Inc., Chicago, USA) and STATA/SE v.12.0 for Win-
dows (StataCorp LP, Texas, USA). The Kolmogorov–Smirnov
test was used to determine the normality of the distribution
of data. Continuous variables with normal distribution are
expressed as mean ± SD, and continuous variables without
normal distribution are expressed as median (range). Categor-
ical variables are presented as number and percentage. Is there
was substantial skewing of urinary sodium values, logarithmic
transformation (Log) was applied to subordinate the skew-
ness of these values. Continuous variables were compared via
the independent samples t-test or the Mann–Whitney U test,
as appropriate. Categorical variables were compared using
the chi-square test. Relationships between numeric param-
eters were analyzed via Pearson’s and Spearman’s correlation
analysis. Stepwise multiple linear regression analysis was per-
formed to identify independent determinants of 24-h systolic
ARV, 24-h diastolic ARV, nighttime systolic ARV, and nighttime
diastolic ARV. The level of statistical signiﬁcance was set at
p < 0.05.
Results
The study included 136 patients (92 male and 44 female). Mean
age of the patients was 50.78 ± 11.1 years. Patient demographic
characteristics, and laboratory and ABPM ﬁndings are shown
in Table 1. BPV and mean 24-h blood pressure levels, and the
correlations between other parameters are shown in Table 2.
Systolic blood pressure level was positively correlated with
log(24-h urinary sodium) (r = 0.294, p = 0.024), BMI (r = 0.183,
p = 0.033), creatinine (r = 0.226, p = 0.008), 24-h systolic ARVlipoprotein; SBP, systolic blood pressure; RAS, renin angiotensin
system.
(r = 0.317, p = 0.001), and nighttime systolic ARV (r = 0.375,
p = 0.001).
Diastolic blood pressure level was positively correlated
with log(24-h urinary sodium) (r = 0.293, p = 0.025), BMI
(r = 0.192, p = 0.030), creatinine (r = 0.201, p = 0.019), 24-h dia-
stolic ARV (r = 0.333, p = 0.006), and nighttime diastolic ARV
(r = 0.384, p = 0.001).
Mean 24-h systolic ARV, mean nighttime systolic ARV,
and mean systolic blood pressure did not signiﬁcantly differ
according gender. Mean 24-h systolic ARV, nighttime systolic
ARV, and mean systolic blood pressure did not signiﬁcantly
differ between the patients that did and did not use anti-
hypertensive drug.
Mean 24-h diastolic ARV, mean nighttime diastolic ARV
blood pressure, and diastolic blood pressure did not sig-
niﬁcantly differ by gender. Mean 24-h diastolic ARV, mean
nighttime diastolic ARV blood pressure, and diastolic blood
pressure did not signiﬁcantly differ between patients that did
and did not use anti-hypertensive medication.
In evaluation of all patients for types of antihypertensive
drugs used, means of blood pressure levels and ARVs for
patients received renin angiotensin system blocker, calcium
channel blocker, and beta blocker were similar (p > 0.05).Log(24-h urinary sodium) did not signiﬁcantly differ
according to gender, or anti-hypertensive drug class, and was
not associated with other laboratory ﬁndings.
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Table 2 – The parameters which correlated with diastolic and systolic average real variability.
Variables 24-h  diastolic ARV Night diastolic ARV 24-h systolic ARV Night systolic ARV
r p r p r p r p
Age 0.092 0.287 0.036 0.675 0.046 0.591 0.034 0.697
BMI 0.222 0.009* 0.114 0.188 0.156 0.071 0.135 0.117
Duration of HT −0.037 0.677 −0.110 0.220 0.091 0.310 0.014 0.876
24-h SBP 0.116 0.177 0.159 0.065 0.317 0.001* 0.375 0.011*
24-h DBP 0.333 0.006* 0.384 0.001* 0.115 0.136 0.117 0.168
Log(24-h urine sodium) 0.381 0.001* 0.320 0.020* 0.371 0.001* 0.329 0.028*
Log(24-h urine sodium)a 0.338 0.004* 0.315 0.031* 0.342 0.002* 0.323 0.025*
24-h urine protein −0.095 0.270 0.074 0.390 0.083 0.335 0.076 0.377
Glucose 0.048 0.661 0.175 0.110 0.074 0.501 0.114 0.299
GFR 0.164 0.066 −0.029 0.740 0.109 0.064 0.008 0.925
Albumin −0.103 0.235 −0.051 0.557 −0.010 0.906 −0.057 0.510
Serum Sodium 0.027 0.754 0.076 0.383 0.031 0.724 0.023 0.787
Creatinine 0.238 0.005* 0.225 0.009* 0.297 0.001* 0.232 0.006*
Triglyceride −0.002 0.984 0.170 0.072 0.002 0.980 0.055 0.532
LDL −0.068 0.438 −0.018 0.838 0.047 0.593 0.028 0.748
Abbreviations: ARV, average real variability; BMI, body mass index; DBP, diastolic blood pressure; GFR, glomerular ﬁltration rate; LDL, low-density
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ulipoprotein; SBP, systolic blood pressure.
a Adjustment for 24-h SBP and 24-h DBP.
∗ p < 0.05 is considered signiﬁcant for statistical analyses.
The positive correlation between log(24-h urinary sodium)
nd 24-h systolic ARV, and nighttime systolic ARV, 24-h dia-
tolic ARV, nighttime diastolic ARV persisted when the effect
f systolic and diastolic blood pressure levels were adjusted
or.
Log(24-h urinary sodium) was positively correlated with
ean 24-h systolic ARV and nighttime systolic ARV (r = 0.371
nd p = 0.001, r = 0.329 and p = 0.028, respectively) (Figs. 1 and 2).
imilarly, log(24-h urinary sodium) was positively correlated
ith mean 24-h diastolic ARV and nighttime diastolic ARV
r = 0.381 and p = 0.001, r = 0.320 and p = 0.020, respectively)
Figs. 3 and 4). The positive correlation also persisted when
ystolic and diastolic blood pressures, gender and BMI  were
djusted for.Age, male gender, BMI, duration of hypertension, and
nti-hypertensive drug class, systolic blood pressure, dia-
tolic blood pressure, log(24-h urine sodium), 24-h urine
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rinary sodium).microalbuminuria, 24-h urine protein excretion, glucose, GFR,
albumin, serum sodium, creatinine, triglyceride, and LDL lev-
els were included in a stepwise regression model. Log(24-h
urine sodium) was observed to be an independent predictor
of BPV based on multivariate regression analysis (Table 3).
Discussion
In the present study there was a positive correlation between
the 24-h urine sodium level and 24-h systolic and 24-h dia-
stolic BPV derived from ABPM in patients diagnosed as primary
hypertension. In addition, there was a positive correlation
between 24-h urine sodium, and mean 24-h systolic and 24-
h diastolic blood pressure levels based on ABPM. The effect
of the quantity of dietary salt intake on blood pressure has
been investigated in numerous epidemiological screening
studies, clinical studies, and experimental animal trials1,22–24;
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Fig. 4 – The correlation with nighttime diastolic ARV and
log(24-h urinary sodium).
however, to the best of our knowledge the present study is the
ﬁrst to investigate the relationship between the quantity of
daily salt intake and ambulatory BPV in hypertensive patients.
Dietary salt intake is a rectiﬁable environmental factor
associated with the pathogenesis of primary hypertension.
Conclusive evidence shows that high-level dietary salt intake
is closely associated with high blood pressure and the devel-
opment of hypertension-related target organ damage20,24,25;
however, many  studies report that high dietary sodium
intake negatively affects the cardiovascular and cerebrovas-
cular systems, independent of elevated blood pressure.26 It
has been suggested that high dietary salt intake adversely
affects remodeling in central and peripheral arteries, and
increases arterial stiffness, independent of increasing blood
pressure.27,28 A study that included normotensive participants
reported that sodium excretion in 24-h urine was positively
Table 3 – Independent predictors for average real varibility by m
Characteristic B ± SE 95
24-h diastolic ARV
24-h DBP 0.043(0.015) 0.010 
Log(24-h urine sodium) 2.601(0.852) 0.916 
Creatinine 3.435(1.458) 0.752 
24-h systolic ARV
24-h SBP 0.054 (0.021) 0.012 
Log(24-h urine sodium) 3.390 (1.094) 1.226 
Creatinine 5.072 (1.867) 1.379 
Nighttime diastolic ARV
24-h DBP 0.048 (0.019) 0.029 
Log(24-h urine sodium) 2.431 (0.821) 0.788 
Creatinine 3.626 (1.733) 1.119 
Nighttime systolic ARV
24-h SBP 0.059 (0.025) 0.010 
Log(24-h urine sodium) 2.462 (0.713) 1.084 
Creatinine 4.448 (1.938) 1.221 
Abbreviations:  ARV, average real variability; DBP, diastolic blood pressure; S
∗ p < 0.05 is considered signiﬁcant for statistical analyses.log(24-h urinary sodium).
correlated with CIMT, independent of blood pressure, which
was suggested to be because a high-salt diet could result in a
ﬂow-related increase in shear stress and induce compensatory
arterial wall thickening without increasing blood pressure.
Endothelium-dependent vascular function and arterial
walls are negatively affected by salt load. These effects of
high salt intake on target organs are linked to the ﬁbrogenic
activity of transforming growth factor (TGF)-beta1, as TGF-
beta1 production has been shown to increase during high
salt intake.29 High salt intake also stimulates vascular growth
by increasing the response to angiotensin 2, vasopressin,
and several growth factors. In general, BPV is considered
to occur due to interaction between environmental, behav-
ioral, neural (central or reﬂex), humoral (insulin, angiotensin
II, bradykinin, endothelin-1, and nitric oxide), and myogenic
factors14,15,30–32; however, the precise factors responsible for
ultivariate regression analysis.
 C.I. p value
R2 = 0.219, p < 0.001
0.091 0.009*
4.285 0.003*
6.519 0.014*
R2 = 0.237, p < 0.001
0.096 0.001*
5.554 0.010*
8.764 0.007*
R2 = 0.225, p < 0.001
0.101 0.003*
3.450 0.038*
7.053 0.028*
R2 = 0.229, p < 0.001
0.109 0.021*
5.056 0.033*
8.875 0.014*
BP, systolic blood pressure.
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PV remain unclear. Sympathovagal reﬂex has been shown to
lay a role in BPV in healthy individuals.32 Additionally, among
he proposed vascular mechanisms of BPV is alteration in arte-
ial distensibility.33 BPV was also associated with changes in
rterial blood vessel walls, including a decrease in arterial
ompliance and an increase in arterial stiffness, in healthy
oung males and patients with cardiovascular disease.17,31
In the present study the observed correlation between 24-h
rine sodium and ambulatory BPV might have been due to the
ffect of salt on the arterial system. Research has suggested
hat salt-sensitive hypertension was associated with the auto-
omic nervous system, and that the sympathetic nervous
ystem was hyperactivated and the parasympathetic system
as inhibited in such patients.34 These ﬁndings are consistent
ith experimental animal studies in which the blood pressure
n rats decreased following sympathetic current blockade or
evering of sympathetic nerves.35,36
The central nervous system is suggested to play an impor-
ant role in producing and maintaining high blood pressure
n individuals with salt-sensitive hypertension. Central and
eﬂex autonomic modulation is known to play a role in the
athophysiology of BPV. Rat studies showed that BPV was
ssociated with reduced cardiac baroreﬂex.37 A study on the
ssociation between BPV and daily salt intake in normoten-
ive individuals reported that dietary salt intake negatively
ffected centrally mediated cardiovascular reﬂex, resulting in
n increase in BPV. Several studies reported that BPV is regu-
ated by sympathovagal balance and arterial distensibility.2–4
ased on these ﬁndings, several mechanisms might contribute
o increased BPV in hypertensive patients with a high-salt diet.
ncreased BPV might be partially due to diminished baroreﬂex
unction associated with increased stiffness and reduced com-
liance in large elastic arteries.26,27 Dietary salt intake might
irectly regulate or activate sympathetic nerve activity, and
ight indirectly modulate BPV; however, the cross-sectional
esign of the present study limits the ability to conclude that
here is a causal relationship between salt intake and BPV.
In conclusion, the major ﬁnding of the present study is that
rimary hypertensive patients with high dietary salt intake
ad high BPV. The relationship between high salt intake and
n increase in BPV was independent of the blood pressure
evel. These ﬁndings suggest that under similar blood pres-
ure levels high salt intake may be associated with increased
PV. Additional larger-scale prospective studies are needed to
urther clarify the relationship between salt intake, BPV, and
ardiovascular disease. Patients with a high-salt diet could be
t increased risk for cardiovascular disease due to the adverse
ffects of BPV on the cardiovascular system. High dietary salt
ntake in hypertensive patients can result in elevated blood
ressure and might contribute to cardiovascular morbidity
ue to an increase in blood pressure.
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